Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Violence experience by perpetrator and associations with HIV/STI risk and infection: a cross-sectional study among female sex workers in Karnataka, south India.

Beksinska A, Prakash R, Isac S, Mohan HL, Platt L, Blanchard J, Moses S, Beattie TS.

BMJ Open. 2018 Sep 11;8(9):e021389. doi: 10.1136/bmjopen-2017-021389.

2.

Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?

Ward Z, Platt L, Sweeney S, Hope VD, Maher L, Hutchinson S, Palmateer N, Smith J, Craine N, Taylor A, Martin N, Ayres R, Dillon J, Hickman M, Vickerman P.

Addiction. 2018 May 17. doi: 10.1111/add.14217. [Epub ahead of print]

PMID:
29774607
3.

Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it?

McGowan CR, Harris M, Platt L, Hope V, Rhodes T.

Int J Drug Policy. 2018 Aug;58:31-36. doi: 10.1016/j.drugpo.2018.04.017. Epub 2018 May 12.

4.

Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia.

Tavitian-Exley I, Maheu-Giroux M, Platt L, Heimer R, Uusküla A, Levina O, Vickerman P, Boily MC.

Int J Drug Policy. 2018 Mar;53:96-105. doi: 10.1016/j.drugpo.2017.11.010. Epub 2018 Jan 5.

PMID:
29306786
5.

Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling.

Platt L, Sweeney S, Ward Z, Guinness L, Hickman M, Hope V, Hutchinson S, Maher L, Iversen J, Craine N, Taylor A, Munro A, Parry J, Smith J, Vickerman P.

Southampton (UK): NIHR Journals Library; 2017 Sep.

6.

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M.

Cochrane Database Syst Rev. 2017 Sep 18;9:CD012021. doi: 10.1002/14651858.CD012021.pub2. Review.

7.

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.

Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M.

Addiction. 2018 Mar;113(3):545-563. doi: 10.1111/add.14012. Epub 2017 Oct 23. Review.

8.

Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.

Mukandavire C, Low A, Mburu G, Trickey A, May MT, Davies CF, French CE, Looker KJ, Rhodes T, Platt L, Guise A, Hickman M, Vickerman P.

AIDS. 2017 May 15;31(8):1181-1190. doi: 10.1097/QAD.0000000000001458.

PMID:
28323752
9.

Decriminalising sex work in the UK.

Grenfell P, Eastham J, Perry G, Platt L.

BMJ. 2016 Aug 16;354:i4459. doi: 10.1136/bmj.i4459. No abstract available.

PMID:
27531130
10.

How effective are brief interventions in reducing alcohol consumption: do the setting, practitioner group and content matter? Findings from a systematic review and metaregression analysis.

Platt L, Melendez-Torres GJ, O'Donnell A, Bradley J, Newbury-Birch D, Kaner E, Ashton C.

BMJ Open. 2016 Aug 11;6(8):e011473. doi: 10.1136/bmjopen-2016-011473. Review.

11.

Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.

Low AJ, Mburu G, Welton NJ, May MT, Davies CF, French C, Turner KM, Looker KJ, Christensen H, McLean S, Rhodes T, Platt L, Hickman M, Guise A, Vickerman P.

Clin Infect Dis. 2016 Oct 15;63(8):1094-1104. doi: 10.1093/cid/ciw416. Epub 2016 Jun 25. Review.

12.

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs.

Platt L, Reed J, Minozzi S, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Hickman M.

Cochrane Database Syst Rev. 2016;2016(1). pii: CD012021. Epub 2016 Jan 12. Update in: Cochrane Database Syst Rev. 2017 Sep 18;9:CD012021.

13.

Prisons as a source of tuberculosis in Russia.

Sarang A, Platt L, Vyshemirskaya I, Rhodes T.

Int J Prison Health. 2016;12(1):45-56. doi: 10.1108/IJPH-07-2014-0022.

PMID:
26933992
14.

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis.

Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, Yanny I, Razavi H, Vickerman P.

Lancet Infect Dis. 2016 Jul;16(7):797-808. doi: 10.1016/S1473-3099(15)00485-5. Epub 2016 Feb 25. Review.

PMID:
26922272
15.

Large-scale implementation of alcohol brief interventions in new settings in Scotland: a qualitative interview study of a national programme.

Fitzgerald N, Platt L, Heywood S, McCambridge J.

BMC Public Health. 2015 Mar 25;15:289. doi: 10.1186/s12889-015-1527-6.

16.

Is the promise of methadone Kenya's solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study.

Rhodes T, Guise A, Ndimbii J, Strathdee S, Ngugi E, Platt L, Kurth A, Cleland C, Vickerman P.

BMJ Open. 2015 Mar 6;5(3):e007198. doi: 10.1136/bmjopen-2014-007198.

17.

Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling.

Vickerman P, Platt L, Jolley E, Rhodes T, Kazatchkine MD, Latypov A.

Int J Drug Policy. 2014 Nov;25(6):1163-73.

PMID:
25449056
18.

Illicit drugs in Central Asia: what we know, what we don’t know, and what we need to know.

Latypov A, Grund JP, El-Bassel N, Platt L, Stöver H, Strathdee S.

Int J Drug Policy. 2014 Nov;25(6):1155-62. No abstract available.

PMID:
25449055
19.

Sex work amongst people who inject drugs in England, Wales and Northern Ireland: findings from a National Survey of Health Harms and Behaviours.

Croxford S, Platt L, Hope VD, Cullen KJ, Parry JV, Ncube F.

Int J Drug Policy. 2015 Apr;26(4):429-33. doi: 10.1016/j.drugpo.2014.09.014. Epub 2014 Oct 5. No abstract available.

PMID:
25449053
20.

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB.

Lancet Glob Health. 2014 Jan;2(1):e23-34. doi: 10.1016/S2214-109X(13)70172-4. Epub 2013 Dec 10.

21.

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB.

Lancet Glob Health. 2013 Dec 10;2(1):23-34.

22.

Factors mediating HIV risk among female sex workers in Europe: a systematic review and ecological analysis.

Platt L, Jolley E, Rhodes T, Hope V, Latypov A, Reynolds L, Wilson D.

BMJ Open. 2013 Jul 24;3(7). pii: e002836. doi: 10.1136/bmjopen-2013-002836. Print 2013.

23.

Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature.

Grenfell P, Baptista Leite R, Garfein R, de Lussigny S, Platt L, Rhodes T.

Drug Alcohol Depend. 2013 May 1;129(3):180-209. doi: 10.1016/j.drugalcdep.2012.11.013. Epub 2013 Jan 8. Review.

PMID:
23306095
24.

Systematic review examining differences in HIV, sexually transmitted infections and health-related harms between migrant and non-migrant female sex workers.

Platt L, Grenfell P, Fletcher A, Sorhaindo A, Jolley E, Rhodes T, Bonell C.

Sex Transm Infect. 2013 Jun;89(4):311-9. doi: 10.1136/sextrans-2012-050491. Epub 2012 Oct 30. Review.

PMID:
23112339
25.

HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy.

Jolley E, Rhodes T, Platt L, Hope V, Latypov A, Donoghoe M, Wilson D.

BMJ Open. 2012 Oct 18;2(5). pii: e001465. doi: 10.1136/bmjopen-2012-001465. Print 2012.

26.

Risk of sexually transmitted infections and violence among indoor-working female sex workers in London: the effect of migration from Eastern Europe.

Platt L, Grenfell P, Bonell C, Creighton S, Wellings K, Parry J, Rhodes T.

Sex Transm Infect. 2011 Aug;87(5):377-84. doi: 10.1136/sti.2011.049544. Epub 2011 May 14.

PMID:
21572111
27.

HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.

Talu A, Rajaleid K, Abel-Ollo K, Rüütel K, Rahu M, Rhodes T, Platt L, Bobrova N, Uusküla A.

Int J Drug Policy. 2010 Jan;21(1):56-63. doi: 10.1016/j.drugpo.2009.02.007. Epub 2009 Apr 22.

PMID:
19395249
28.

Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.

Platt L, Sutton AJ, Vickerman P, Koshkina E, Maximova S, Latishevskaya N, Hickman M, Bonell C, Parry J, Rhodes T.

Eur J Public Health. 2009 Aug;19(4):428-33. doi: 10.1093/eurpub/ckp041. Epub 2009 Apr 5.

PMID:
19349288
29.

Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.

Judd A, Rhodes T, Johnston LG, Platt L, Andjelkovic V, Simić D, Mugosa B, Simić M, Zerjav S, Parry RP, Parry JV.

BMC Infect Dis. 2009 Feb 9;9:14. doi: 10.1186/1471-2334-9-14.

30.

Police violence and sexual risk among female and transvestite sex workers in Serbia: qualitative study.

Rhodes T, Simic M, Baros S, Platt L, Zikic B.

BMJ. 2008 Jul 30;337:a811. doi: 10.1136/bmj.a811.

31.

Access to syringes in three Russian cities: implications for syringe distribution and coverage.

Sarang A, Rhodes T, Platt L.

Int J Drug Policy. 2008 Apr;19 Suppl 1:S25-36. doi: 10.1016/j.drugpo.2007.11.008. Epub 2008 Mar 3.

PMID:
18313910
32.

High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.

Uusküla A, Kals M, Rajaleid K, Abel K, Talu A, Rüütel K, Platt L, Rhodes T, Dehovitz J, Des Jarlais D.

J Public Health (Oxf). 2008 Jun;30(2):119-25. doi: 10.1093/pubmed/fdn014. Epub 2008 Feb 28.

33.

Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence.

Platt L, Rhodes T, Hickman M, Mikhailova L, Lisetsky K, Sarang A, Lewis K, Parry J.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):623-31. doi: 10.1097/QAI.0b013e318165dbf7.

PMID:
18209680
34.

Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: Qualitative study.

Sarang A, Rhodes T, Platt L, Kirzhanova V, Shelkovnikova O, Volnov V, Blagovo D, Rylkov A.

Addiction. 2006 Dec;101(12):1787-96.

PMID:
17156178
35.

Exploring barriers to 'respondent driven sampling' in sex worker and drug-injecting sex worker populations in Eastern Europe.

Simic M, Johnston LG, Platt L, Baros S, Andjelkovic V, Novotny T, Rhodes T.

J Urban Health. 2006 Nov;83(6 Suppl):i6-15.

36.

Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia.

Platt L, Wall M, Rhodes T, Judd A, Hickman M, Johnston LG, Renton A, Bobrova N, Sarang A.

J Urban Health. 2006 Nov;83(6 Suppl):i39-53.

37.

High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.

Platt L, Bobrova N, Rhodes T, Uusküla A, Parry JV, Rüütel K, Talu A, Abel K, Rajaleid K, Judd A.

AIDS. 2006 Oct 24;20(16):2120-3.

PMID:
17053361
38.

Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities.

Platt L, Rhodes T, Judd A, Koshkina E, Maksimova S, Latishevskaya N, Renton A, McDonald T, Parry JV.

Am J Public Health. 2007 Mar;97(3):478-85. Epub 2006 Oct 3.

39.

Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives.

Rhodes T, Platt L, Sarang A, Vlasov A, Mikhailova L, Monaghan G.

J Urban Health. 2006 Sep;83(5):911-25.

40.

Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia.

Hickman M, Hope V, Platt L, Higgins V, Bellis M, Rhodes T, Taylor C, Tilling K.

Drug Alcohol Rev. 2006 Mar;25(2):131-40.

PMID:
16627302
41.

Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.

Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV.

Addiction. 2006 Feb;101(2):252-66.

PMID:
16445554
42.

Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.

Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV.

Int J STD AIDS. 2005 Nov;16(11):749-54.

PMID:
16303071
43.

Impact of gender and sex work on sexual and injecting risk behaviors and their association with HIV positivity among injecting drug users in an HIV epidemic in Togliatti City, Russian Federation.

Platt L, Rhodes T, Lowndes CM, Madden P, Sarang A, Mikhailova L, Renton A, Pevzner Y, Sullivan K, Khutorskoy M.

Sex Transm Dis. 2005 Oct;32(10):605-12.

PMID:
16205301
44.

The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage.

Platt L, Hickman M, Rhodes T, Mikhailova L, Karavashkin V, Vlasov A, Tilling K, Hope V, Khutorksoy M, Renton A.

Addiction. 2004 Nov;99(11):1430-8.

PMID:
15500596
45.

Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: maximizing the protective effects of syringe distribution.

Rhodes T, Judd A, Mikhailova L, Sarang A, Khutorskoy M, Platt L, Lowndes CM, Renton A.

J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):293-300.

PMID:
15076245
46.

Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation.

Lowndes CM, Alary M, Platt L.

Sex Transm Dis. 2003 Jan;30(1):46-8. No abstract available.

PMID:
12514442

Supplemental Content

Loading ...
Support Center